Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery [PDF]
Advances in Laboratory Medicine, 2020 The postoperative period of cardiac surgery (CS) is associated with the development of major adverse cardiovascular events (MACEs). However, the evaluation of MACE after CS by means of biomarkers is poorly developed.
Imperiali Claudia E. +3 more
doaj +2 more sources
Cystatin C as a Predictor of Major Adverse Cardiovascular Event in Patients with Acute Myocardial Infarction Without Cardiogenic Shock and Renal Impairment After Coronary Intervention [PDF]
International Journal of General Medicine, 2023 Trisulo Wasyanto,1 Ahmad Yasa,1 Yoga Yudhistira2 1Department of Cardiology and Vascular Medicine, Faculty of Medicine, Sebelas Maret University/Dr. Moewardi Hospital, Surakarta, Indonesia; 2Department of Cardiology and Vascular Medicine, Faculty of ...
Wasyanto T, Yasa A, Yudhistira Y
doaj +2 more sources
Major adverse cardiovascular event (MACE) after percutaneous coronary intervention in one-year follow-up study [PDF]
Electronic Physician, 2018 Background: Percutaneous coronary intervention (PCI) is the most common revascularization procedure, with over 1 million performed each year, worldwide.
Hossein Farshidi +5 more
doaj +2 more sources
Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review [PDF]
BMC Medical Research Methodology, 2021 Background Major adverse cardiovascular events (MACE) are increasingly used as composite outcomes in randomized controlled trials (RCTs) and observational studies.
Elliott Bosco +4 more
doaj +2 more sources
Long-Term Major Adverse Kidney and Cardiovascular Events in Predialysis Chronic Kidney Disease: A Real-World Cohort Study [PDF]
MedicinaBackground and Objectives: Long-term renal and cardiovascular outcomes represent major clinical burdens in predialysis chronic kidney disease (CKD).
Ayşe Karaduru Avcı +6 more
doaj +2 more sources
Journal of the Practice of Cardiovascular Sciences, 2021 Objectives: Bifurcation percutaneous coronary interventions (PCIs) remain a challenging subset with tussle between provisional versus dedicated (i.e. two-stent) stenting.
Danny Kumar, Sundeep Mishra
doaj +1 more source
The Role of High Sensitivity C-Reactive Protein as a Predictor in Outcome ST - Elevation Acute Myocardial Infarction Patients Underwent the Primary Percutaneous Coronary Intervention [PDF]
Modern Medicine, 2023 Background: The role of inflammation is an important part for the process of acute myocardial infarction. Inflammation of blood vessel walls and inflammatory response are considered as the main pathogenesis of atherothrombosis in ST elevation of ...
IGde Rurus SURYAWAN +3 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023 Background This study aimed to compare the performance of established cardiovascular risk algorithms in Korean patients with new‐onset rheumatoid arthritis.
Jae Hyun Kim +5 more
doaj +1 more source
Prediabetes increases the risk of major limb and cardiovascular events
Cardiovascular Diabetology, 2023 Background Prediabetes, an intermediate stage between normal blood sugar levels and a diabetes mellitus diagnosis, is increasing in prevalence. Severe prediabetes is associated with a similar risk of complications as diabetes, but its relationship with ...
Jung-Chi Hsu +4 more
doaj +1 more source
Frontiers in Medicine, 2021 The US Food and Drug Administration in 2008 required new type 2 diabetes (T2D) medications to be subject to cardiovascular outcomes safety requirements.
Henrik K. Nielsen +2 more
doaj +1 more source